This mid-cap multibagger Pharma company signs MOA with IIT Kanpur for novel gene therapy assets!
This mid-cap multibagger Pharma company signs MOA with IIT Kanpur for novel gene therapy assets!

This mid-cap multibagger Pharma company signs MOA with IIT Kanpur for novel gene therapy assets!

The company delivered exceptional returns of 251 per cent over the past 3 years.

Siddharth Mane Article rating: 3.8

The company delivered exceptional returns of 251 per cent over the past 3 years, while over the past 5 years, it provided remarkable returns of 242 per cent.    

 

DSIJ MINDSHARE

Mkt Commentary17-May, 2024

Multibaggers17-May, 2024

Mindshare16-May, 2024

Multibaggers16-May, 2024

Bonus and Spilt Shares16-May, 2024

Knowledge

General15-May, 2024

MF14-May, 2024

MF14-May, 2024

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR